Myeloproliferative disorders in pregnancy

Hematol Oncol Clin North Am. 2011 Apr;25(2):261-75, vii. doi: 10.1016/j.hoc.2011.01.008.

Abstract

This article reviews pregnancy outcome in women diagnosed with a myeloproliferative neoplasm (MPN), and discusses possible risk markers and the pathogenesis of poor pregnancy outcome. An outline of the key factors regarding the diagnosis and management of MPN in women of reproductive potential is followed by a description of the authors' management strategy for standard and high-risk pregnancy in MPN patients.

Publication types

  • Review

MeSH terms

  • Abortion, Habitual / diagnosis
  • Abortion, Habitual / mortality
  • Abortion, Habitual / pathology
  • Abortion, Habitual / therapy
  • Adult
  • Age Factors
  • Female
  • Humans
  • Incidence
  • Infertility, Female / diagnosis
  • Infertility, Female / mortality
  • Infertility, Female / pathology
  • Infertility, Female / therapy
  • Myeloproliferative Disorders / diagnosis
  • Myeloproliferative Disorders / mortality*
  • Myeloproliferative Disorders / pathology
  • Myeloproliferative Disorders / therapy
  • Pregnancy
  • Pregnancy Complications, Neoplastic / diagnosis
  • Pregnancy Complications, Neoplastic / mortality*
  • Pregnancy Complications, Neoplastic / pathology
  • Pregnancy Complications, Neoplastic / therapy